belhaven-biopharma | Media Room | PressRelease.com

Tagged belhaven-biopharma

Belhaven Biopharma Announces Groundbreaking Clinical Results for Nasdepi, the Revolutionary Nasal Dry Powder Epinephrine Product

Press Release Feb 8, 2024

Belhaven Biopharma Announces Groundbreaking Clinical Results for Nasdepi, the Revolutionary Nasal Dry Powder Epinephrine Product

News of the Successful Trial Comes Amid an Oversubscribed Investor Round and Preparation for Series A Financing Round

Belhaven Biopharma Achieves Significant Milestones in Advancing Nasdepi - a Revolutionary Nasal Dry Powder Epinephrine Product

Press Release Nov 28, 2023

Belhaven Biopharma Achieves Significant Milestones in Advancing Nasdepi - a Revolutionary Nasal Dry Powder Epinephrine Product

Several key accomplishments completed to finish 2023 and create a strong foundation for 2024.

First
Prev

1

Next
Last